Esperoct 3000 Unit (Antihemophilic Factor Viii (Recombinant, B-Domain Truncated), Pegylated POWDER FOR SOLUTION) 3000 UNIT

Esperoct 3000 Unit is a recombinant, pegylated antihemophilic factor VIII used to manage bleeding episodes in hemophilia A. This intravenous powder for solution is designed for effective clotting support.

Strength

3000 UNIT

Manufacturer / TM Owner

NOVO NORDISK CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Esperoct 3000 Unit is primarily used for the treatment and prevention of bleeding episodes in individuals with hemophilia A, a condition characterized by a deficiency in factor VIII. It is also used to manage bleeding during surgical procedures in these patients. The medication works by replacing the missing clotting factor, helping to control bleeding and promote healing.

Side Effects

Common effects of Esperoct 3000 Unit may include localized reactions at the injection site, such as redness, swelling, or itching. Some users may experience mild to moderate headaches or nausea. These effects are generally temporary and should subside as the body adjusts to the medication.

Precautions & Warnings

Esperoct 3000 Unit should be handled with care, ensuring proper storage and preparation. It is essential to follow the healthcare provider's instructions for administration. Individuals with known allergies to any components of the medication should avoid its use. Regular monitoring may be required to assess the effectiveness and safety of the treatment.

Avoid Interactions

Esperoct 3000 Unit may interact with certain medications, including those that affect blood clotting. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances that affect blood clotting should be used with caution.

Frequently Asked Questions

Esperoct 3000 Unit is used to manage bleeding episodes and provide clotting support in individuals with hemophilia A.

Esperoct 3000 Unit is administered intravenously as a powder for solution, typically prepared and injected by a healthcare professional.

Common side effects may include localized reactions at the injection site, headaches, and nausea.

Yes, Esperoct 3000 Unit can be used to manage bleeding during surgical procedures in patients with hemophilia A.

Long-term use of Esperoct 3000 Unit should be monitored by a healthcare provider to ensure safety and effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.